Identifying appropriate patients to treat: a case-based approach.
Topic:
Lipids
Speaker:
Professor C. Cannon (Boston, US)
Professor A. Catapano (Milan, IT)
Professor S. Nicholls (Melbourne, AU)
Doctor P. Ridker (Boston, US)
Doctor J. Robinson (Iowa, US)
Sponsored by Sanofi and Regeneron
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Professor Christopher Paul Cannon
Brigham and Women's Hospital, Boston (United States of America)
38
presentations
0
follower
Professor Alberico Catapano
IRCCS - MultiMedica, Milan (Italy)
46
presentations
3
followers
Professor Stephen Nicholls
Monash University, Melbourne (Australia)
51
presentations
4
followers
Doctor Paul M Ridker
Brigham and Women's Hospital, Boston (United States of America)
34
presentations
3
followers
Doctor Jennifer Robinson
University of Iowa, Iowa (United States of America)
12
presentations
0
follower
6 more presentations in this session
Introduction - PSCK9 inhibition: a new horizon in LDL-C management.
Speaker: Professor C. Cannon (Boston, US)
PCSK9 inhibition: the data today and tomorrow.
Speaker: Professor S. Nicholls (Melbourne, AU)
Access the full session
PSCK9 inhibition: a new horizon in LDL-C management
Speakers:
Professor C. Cannon, Professor A. Catapano, Professor S. Nicholls, Doctor P. Ridker, Doctor J. Robinson...
About the event
ESC 365 is supported by
